Drug Database
Back to search

France· FR:67392754

ATOVAQUONE BIOGARAN 750 mg/5mL, suspension buvable

A atovaquone product containing atovaquone, registered in France by BIOGARAN, on the national reimbursement list. The same ATC class is registered in 11 of our 19 countries.

Reimbursed in France (Assurance maladie)ATC P01AX06

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedATOVAQUONE BIOGARAN 750 mg/5mL, suspe…ATCP01AX06REGISTER NO.FR:67392754PACKS LISTED1CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about atovaquoneAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Atovaquone is registered in 11 of 19 countries.

Countries holding a registration under ATC P01AX06 (atovaquone), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 5 of them publish a price we can compare per daily dose
Search atovaquone products by name

Atovaquone · ATC P01AX06

11 / 19 countries

  • Belgiumprice
  • Canada
  • Denmark
  • Franceprice
  • Germany
  • Netherlands
  • Norwayprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
ATOVAQUONE
Manufacturer
BIOGARAN
Country
France (FR)
ATC code
P01AX06
ATC class
Atovaquone
Defined daily dose
1.5 g, O
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • cip13
    3400930189948
    1 flacon(s) en plastique polyéthylène haute densité (PEHD) de 226 mL avec fermeture de sécurité enfant avec cuillère-mesure polypropylène
    EUR 228.47

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

182 interactions on record for atovaquone.

Graded by severity as the source publishes them — 8 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check atovaquone against other medicinesHow interaction checks work

Atovaquone · interactions on record

182 records

  • 8 severe
  • 32 moderate
  • 4 minor
  • 133 info

Most severe, free to view

  • MipomersenC10AX11severe
  • LomitapideC10AX12severe
  • EfavirenzJ05AG03severe
  • PexidartinibL01EX15severe

5 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Atovaquone in 9 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All atovaquone products

Authorised across Europe · EMA

The same active substance is authorised in 12 EEA countries. Names it is sold under:

  • Belgium · Wellvone
  • Germany · Atovaquon Glenmark, Wellvone
  • Denmark · Atovaquone Glenmark
  • Spain · Atovacuona Glenmark, Wellvone
  • United Kingdom (Northern Ireland) · Atovaquone Amarox, Atovaquone Glenmark Pharmaceuticals Europe
  • Greece · Atovaquone Vocate, Wellvone
  • Italy · Atovaquone Glenmark, Wellvone
  • Luxembourg · Wellvone
  • Netherlands · Atovaquon Glenmark, Wellvone
  • Norway · Atovaquone Glenmark
  • Portugal · Atovaquona Kabi, Wellvone
  • Sweden · Atovaquone Glenmark, Wellvone

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/a74f9417-1b88-4bfa-b484-d5289f76bcbf
GET /v1/drugs/a74f9417-1b88-4bfa-b484-d5289f76bcbf?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "67392754",
  "date_amm": "2019-09-17",
  "type_amm": "Procédure de reconnaissance mutuelle",
  "numero_ue": null,
  "substance": "ATOVAQUONE",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "suspension buvable",
  "voies_administration": "orale",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}
API referenceMCP serverPlans

See everything about atovaquone.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console